Local anesthetic dosing and toxicity of adult truncal catheters: a narrative review of published practice
Regional Anesthesia & Pain Medicine · 2024-03 · 49 (3) · 209-222
DOI: 10.1136/rapm-2023-104667 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Regional Anesthesia & Pain Medicine, online erschienen am 14.07.2023. Verfasst von Brittani Bungart und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Anesthetics, Local, Nerve Block. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 268 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIGMS NIH HHS, NIH.
Abstract (Originalsprache)
Background/importance Anesthesiologists frequently use truncal catheters for postoperative pain control but with limited characterization of dosing and toxicity.
Objective
We reviewed the published literature to characterize local anesthetic dosing and toxicity of paravertebral and transversus abdominis plane catheters in adults. Evidence review We searched the literature for bupivacaine or ropivacaine infusions in the paravertebral or transversus abdominis space in humans dosed for 24 hours. We evaluated bolus dosing, infusion dosing and cumulative 24-hour dosing in adults. We also identified cases of local anesthetic systemic toxicity and toxic blood levels.
Findings
Following screening, we extracted data from 121 and 108 papers for ropivacaine and bupivacaine respectively with a total of 6802 patients. For ropivacaine and bupivacaine, respectively, bolus dose was 1.4 mg/kg (95% CI 0.4 to 3.0, n=2978) and 1.0 mg/kg (95% CI 0.18 to 2.1, n=2724); infusion dose was 0.26 mg/kg/hour (95% CI 0.06 to 0.63, n=3579) and 0.2 mg/kg/hour (95% CI 0.06 to 0.5, n=3199); 24-hour dose was 7.75 mg/kg (95% CI 2.1 to 15.7, n=3579) and 6.0 mg/kg (95% CI 2.1 to 13.6, n=3223). Twenty-four hour doses exceeded the package insert recommended upper limit in 28% (range: 17%–40% based on maximum and minimum patient weights) of ropivacaine infusions and 51% (range: 45%–71%) of bupivacaine infusions. Toxicity occurred in 30 patients and was associated with high 24-hour dose, bilateral catheters, cardiac surgery, cytochrome P-450 inhibitors and hypoalbuminemia.
Conclusion
Practitioners frequently administer ropivacaine and bupivacaine above the package insert limits, at doses associated with toxicity. Patient safety would benefit from more specific recommendations to limit excessive dose and risk of toxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
- Department of Anaesthesia, Harvard Medical School, Boston, Massachusetts, USA.
- Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA fettiplace@gmail.com.
ORCID-Profile: Brittani Bungart, Michael Fettiplace
Förderung
- NIGMS NIH HHS
- NIH
Zitieren
APA
Bungart, B., Joudeh, L., & Fettiplace, M. (2024). Local anesthetic dosing and toxicity of adult truncal catheters: a narrative review of published practice. Regional Anesthesia & Pain Medicine, 49(3), 209-222. https://doi.org/10.1136/rapm-2023-104667
Vancouver
Bungart B, Joudeh L, Fettiplace M. Local anesthetic dosing and toxicity of adult truncal catheters: a narrative review of published practice. Regional Anesthesia & Pain Medicine. 2024;49(3):209-222. doi:10.1136/rapm-2023-104667
BibTeX
@article{Bungart2024,
author = {Bungart, Brittani and Joudeh, Lana and Fettiplace, Michael},
title = {Local anesthetic dosing and toxicity of adult truncal catheters: a narrative review of published practice},
journal = {Regional Anesthesia & Pain Medicine},
year = {2024},
volume = {49},
number = {3},
pages = {209--222},
doi = {10.1136/rapm-2023-104667}
}
EUVIMED